Dynamic Monitoring of Ongoing Clinical Trials
Open Access
- 8 March 2021
- journal article
- research article
- Published by Taylor & Francis in Statistics in Biopharmaceutical Research
- Vol. 14 (4) , 580-591
Abstract
In late 2019, the US FDA updated a new Guidance for Industry on Adaptive Designs for Clinical Trials of Drugs and Biologics. The guideline encourages developing and implementing innovative trial designs for future clinical trials. Group sequential, sample size re-estimation, and adaptive group sequential procedures have been very useful for improving the efficiency of conducting trials for decades. However, they face some challenges in operational aspects which limited their potentials. In this paper we introduce a procedure that addresses these issues. Our proposed procedure has the capability of providing anytime accessibility of the whole up-to-date data history. The procedure is largely built on the proven adaptive group sequential design theories and combined with advanced eClinical technologies in trial management to elevate the trial design and monitoring to a more dynamic level. The construct of a new trial monitoring screen is illustrated with real trial examples. The advantages of anytime accessibility of data and the monitoring a trial with the whole data history and trend are delineated. Data monitoring committees, sponsors and regulatory authorities are important stakeholders in the discussion of how future clinical trials should be monitored with respect to timing and frequency.Keywords
This publication has 30 references indexed in Scilit:
- Spending functions and continuous‐monitoring boundariesStatistics in Medicine, 2012
- Sample Size Re-Estimation for Adaptive Sequential Design in Clinical TrialsJournal of Biopharmaceutical Statistics, 2008
- Increasing the sample size when the unblinded interim result is promisingStatistics in Medicine, 2004
- A sample size adjustment procedure for clinical trials based on conditional powerBiostatistics, 2002
- Sample size re‐estimation – journey for a decadeStatistics in Medicine, 2001
- Semiparametric Efficiency and its Implication on the Design and Analysis of Group-Sequential StudiesJournal of the American Statistical Association, 1997
- Use of spending functions for occasional or continuous monitoring of data in clinical trialsStatistics in Medicine, 1993
- The Use of Interim Analysis for Sample Size AdjustmentDrug Information Journal, 1993
- Sample size re-estimation without unblinding for normally distributed outcomes with unknown varianceCommunications in Statistics - Theory and Methods, 1992
- Repeated Significance Testing for a General Class of Statistics Used in Censored Survival AnalysisJournal of the American Statistical Association, 1982